Aditxt, Inc. Secured Debt
Aditxt, Inc. (ADTX) had Secured Debt of $5.00 million as of 2024-01-02, per its 10-Q filed 2024-05-20.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:SecuredDebt · last filed 2024-05-20
- 2024-01-02: Secured Debt $5.00M.
- 2023-12-31: Secured Debt $5.20M.
| Period end | Secured Debt |
|---|---|
| 2024-01-02 | $5.00M 10-Q · filed 2024-05-20 |
| 2023-12-31 | $5.20M 10-K · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |